Akela Pharma Inc. AKLPF

Emmelot, Rudy - CEO

[Biostocks01]

He still buys...

Filing Date	Transaction Date	Insider Name	Ownership Type	Securities	Nature of transaction	# or value acquired or disposed of	Unit Price
Apr 10/12	Apr 4/12	Emmelot, Rudy	Direct Ownership	Common Shares	10 - Acquisition in the public market	4,000	.153 USD
Apr 10/12	Apr 4/12	Emmelot, Rudy	Direct Ownership	Common Shares	10 - Acquisition in the public market	4,000	.153 USD
Apr 10/12	Apr 4/12	Emmelot, Rudy	Direct Ownership	Common Shares	10 - Acquisition in the public market	4,000	.148 USD
Apr 10/12	Apr 4/12	Emmelot, Rudy	Direct Ownership	Common Shares	10 - Acquisition in the public market	4,000	.138 USD
Apr 10/12	Apr 4/12	Emmelot, Rudy	Direct Ownership	Common Shares	10 - Acquisition in the public market	4,000	.138 USD
Apr 10/12	Apr 4/12	Emmelot, Rudy	Direct Ownership	Common Shares	10 - Acquisition in the public market	4,000	.138 USD
Apr 10/12	Apr 4/12	Emmelot, Rudy	Direct Ownership	Common Shares	10 - Acquisition in the public market	4,000	.138 USD
Apr 10/12	Apr 4/12	Emmelot, Rudy	Direct Ownership	Common Shares	10 - Acquisition in the public market	4,000	.138 USD
Apr 10/12	Apr 4/12	Emmelot, Rudy	Direct Ownership	Common Shares	10 - Acquisition in the public market	4,000	.133 USD
Apr 10/12	Apr 4/12	Emmelot, Rudy	Direct Ownership	Common Shares	10 - Acquisition in the public market	3,000	.143 USD
Sign up for an account or login above to see all SEDI filings within the past 6 months.

[Hotoffthepress]

This post has been removed in accordance with Community Policy

[Consultor1]

I would almost think that maybe Mckee is selling off his shares, as it does seem that everytime we get a little momentum some one knocks it down. I don't believe he has to show insider info any more, correct me if i'm wrong.   Consultor1

[Biostocks01]

Good morning Consultot1, It is a good point, I also thought of it...but it is not for its advantage to sell his shares because he knows very well the potential of appreciation. I think that it is a strategy of accumulation... Bio... ps I still buy

[Consultor1]

Yes you may be right, however if he was pushed aside his thinking might not be the same as our.   Consultor1

[Biostocks01]

Hello Consultor1,  I hope you are well!! I was wondering if you had an email address to communicate with the new CEO, Emmelot?? I have some questions to ask before the annual meeting of shareholders. Thank you in advance!! Bio